Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

NVHR releases statement on New York Times article 'Hope against Hepatitis C'

NVHR releases statement on New York Times article 'Hope against Hepatitis C'

Achillion nominates ACH-2928 NS5A clinical candidate for treatment of HCV

Achillion nominates ACH-2928 NS5A clinical candidate for treatment of HCV

Onyx begins Phase 3 trial of carfilzomib in combination with lenalidomide, dexamethasone for relapsed myeloma

Onyx begins Phase 3 trial of carfilzomib in combination with lenalidomide, dexamethasone for relapsed myeloma

Aegera reports data from Phase 1 portion of combination AEG35156 Phase 1-2 study for primary liver cancer

Aegera reports data from Phase 1 portion of combination AEG35156 Phase 1-2 study for primary liver cancer

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

NVHR welcomes national HIV/AIDS strategy that recognizes better care for HIV/AIDS, viral hepatitis patients

Amorfix grants Biogen Idec exclusive worldwide rights to lead ALS monoclonal antibodies

Amorfix grants Biogen Idec exclusive worldwide rights to lead ALS monoclonal antibodies

Samsung Medical Center, Pfizer form research partnership

Samsung Medical Center, Pfizer form research partnership

The Samuel Waxman Cancer Research Foundation announces research grants totaling $1.54 million

The Samuel Waxman Cancer Research Foundation announces research grants totaling $1.54 million

Amorfix Life Sciences uses A(4) test to detect accumulation of Abeta in mouse models of AD

Amorfix Life Sciences uses A(4) test to detect accumulation of Abeta in mouse models of AD

Interim progress from Phase III TeloVac study of GV1001 vaccine announced

Interim progress from Phase III TeloVac study of GV1001 vaccine announced

DGP/tTG Screen assay may be best initial test for suspected celiac disease: Study

DGP/tTG Screen assay may be best initial test for suspected celiac disease: Study

Study suggests Perfusion CT as noninvasive tool in diagnosis of hepatic toxicity

Study suggests Perfusion CT as noninvasive tool in diagnosis of hepatic toxicity

Early knowledge of HCC response to TACE determines treatment success: Research article

Early knowledge of HCC response to TACE determines treatment success: Research article

Local anesthetics have potential therapeutic effects on IBD: Research article

Local anesthetics have potential therapeutic effects on IBD: Research article

Researchers evaluate safety and feasibility of STARR procedure for ODS

Researchers evaluate safety and feasibility of STARR procedure for ODS

Study reveals X+ allele of APOB gene as another risk factor of gallstone formation after gastrectomy

Study reveals X+ allele of APOB gene as another risk factor of gallstone formation after gastrectomy

Report investigates clear cell ICC

Report investigates clear cell ICC

Common glucose test accurately predicts Type II adult-onset diabetes, study finds

Common glucose test accurately predicts Type II adult-onset diabetes, study finds

TWINCORE researchers develop new model approaches for HCV research

TWINCORE researchers develop new model approaches for HCV research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.